Revvity Inc
(NYSE:RVTY)
$
125.96
1.14 (0.91%)
Market Cap: 15.54 Bil
Enterprise Value: 17.48 Bil
PE Ratio: 91.47
PB Ratio: 1.97
GF Score: 82/100 
Revvity Inc at TD Cowen Health Care Conference Transcript
Mar 04, 2024 / 02:10PM GMT
Release Date Price:
$108.51
(+1.30%)
Daniel Gregory Brennan
TD Cowen, Research Division - MD and Senior Tools & Diagnostics Analyst
(technical difficulty) So I'm Dan Brennan, (technical difficulty) Prahlad Singh, President and CEO of Revvity. So Prahlad, welcome.
Prahlad R. Singh
Revvity, Inc. - CEO, President & Director
Thank you.
Daniel Gregory Brennan
TD Cowen, Research Division - MD and Senior Tools & Diagnostics Analyst
And thanks for coming. Listen, I will check my e-mail a couple of times throughout if any of you want to pose any questions. I'll see if I can weave those in. We have a list and a little over 30 minutes to tackle it.
Questions & Answers
Daniel Gregory Brennan
TD Cowen, Research Division - MD and Senior Tools & Diagnostics Analyst
So maybe I thought just to kick it off, obviously, the long-term guide. You guys just took it down from 10% to 6% to 8%. You've got 75 to 100 basis points of EBIT expansion. You kind of tweaked that down to 75 basis points, still
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers